mizolastine

BACKGROUND An IgE-mediated allergic reaction to an antihistamine sounds like a paradox and is rare. OBJECTIVE To describe 2… (More)

BACKGROUND Treatment of primary acquired cold urticaria (CU) is quite difficult because of variable clinical effectiveness and… (More)

BACKGROUND Levocetirizine is the active enantiomer of cetirizine, a potent drug with little metabolism widely used for allergic… (More)

Mizolastine is a second generation antihistamine agent approved in Europe for the treatment of allergic rhinitis and skin… (More)

AIM To assess the long-term safety and efficacy of the H1-receptor antagonist mizolastine in the symptomatic treatment of chronic… (More)

A population analysis of the kinetics of mizolastine was performed from concentrations on 449 allergic patients, using the… (More)

A two-centre, double-blind, randomized, placebo (P)-controlled, parallel-group study was conducted in the UK to examine the… (More)

Mizolastine is a new, nonsedating antihistamine providing satisfactory symptom relief in allergic rhinitis and urticaria. The… (More)

1. Mizolastine, a new benzimidazole derivative with potent selective, non-sedative H1-histamine antagonist activity was compared… (More)

The acute effect of doses of mizolastine 5, 10, 20 and 40 mg, an active control (clemastine 2 mg) and placebo on actual car… (More)